Good ACE, bad ACE do battle in lung injury, SARS.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16079870.
- Also identified by PMC identifier 7095949.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two studies show how the enzyme ACE2 protects against lung injury caused by SARS and other agents. ACE2 seems to counteract the effects of ACE, which are more damaging (pages 875–879).
Medical subject headings
- Carboxypeptidases
- Pulmonary Alveoli
- Respiratory Distress Syndrome
- Severe acute respiratory syndrome-related coronavirus
- Severe Acute Respiratory Syndrome